NCT05028140 - Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus | Biotech Hunter

Enrollment

480

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

September 30, 2026

Conditions

Type II Diabetes

Interventions

DRUG

PIEMONTE

Piemonte association 1 coated tablet once a day

OTHER

PIEMONTE PLACEBO

Placebo of Piemonte association 1 coated tablet once a day

DRUG

EMPAGLIFLOZIN

Empagliflozin 25 mg 1 coated tablet once a day

OTHER

PLACEBO EMPAGLIFLOZIN

Placebo of empagliflozin 25 mg 1 coated tablet once a day

DRUG

PIOGLITAZONE

Pioglitazone 30 mg 1 tablet once a day

OTHER

PLACEBO PIOGLITAZONE

Placebo of pioglitazone 30 mg 1 tablet once a day